T. Rowe Price Associates’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07M | Buy |
78,179
+8,090
| +12% | +$215K | ﹤0.01% | 1619 |
|
|
2025
Q1 | $1.69M | Buy |
70,089
+9,365
| +15% | +$226K | ﹤0.01% | 1687 |
|
|
2024
Q4 | $2.44M | Sell |
60,724
-1,945
| -3% | -$78.3K | ﹤0.01% | 1555 |
|
|
2024
Q3 | $3.97M | Buy |
62,669
+2,999
| +5% | +$190K | ﹤0.01% | 1370 |
|
|
2024
Q2 | $3.16M | Sell |
59,670
-1,747
| -3% | -$92.6K | ﹤0.01% | 1384 |
|
|
2024
Q1 | $5.04M | Buy |
61,417
+6,181
| +11% | +$507K | ﹤0.01% | 1216 |
|
|
2023
Q4 | $1.03M | Buy |
55,236
+13,784
| +33% | +$257K | ﹤0.01% | 1855 |
|
|
2023
Q3 | $459K | Sell |
41,452
-4,112
| -9% | -$45.5K | ﹤0.01% | 2145 |
|
|
2023
Q2 | $739K | Buy |
+45,564
| New | +$739K | ﹤0.01% | 1949 |
|